Long Term Results of Combined Transpupillary Thermotherapy (TTT) Indocyanine Green (ICG) Based Photodynamic Therapy (PDT) in Choroidal Melanoma
NCT ID: NCT01253759
Last Updated: 2013-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
46 participants
OBSERVATIONAL
2009-01-31
2009-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Primary Tube Versus Trabeculectomy Study
NCT00666237
Direct vs. Conventional SLT in Open-Angle Glaucoma: A RCT
NCT06925477
Retinal Vascular Reactivity in Subjects With Newly Diagnosed Glaucoma Before and After Selective Laser Trabeculoplasty
NCT01209975
Systemic Glutathione Level in Normal Tension Glaucoma
NCT00570362
Deep Sclerectomy Versus Trabeculectomy in Normal Tension Glaucoma
NCT05371977
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Combined treatment of Transpupillary Thermotherapy and ICG-based photodynamic therapy (PDT)
TTT + ICG-based PDT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TTT + ICG-based PDT
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients older than 18 years old.
* Patients who can read and signed the informed consent.
Exclusion Criteria
* Patients with another active ocular disease.
18 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
New England Retina Associates
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter E. Liggett
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter E Liggett, MD
Role: STUDY_DIRECTOR
New England Retina Associates
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New England Retina Associates
Hamden, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NERA-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.